Abstract
A pilot study showed that single doses of imipramine (100 mg) produced a maximum reduction in salivation after 3 h which persisted for 72 h after drug. Effects after 3 h were reproducible in 3 subjects and differed from control levels on all 6 occasions of testing. A double-blind study in 6 subjects was then carried out to ascertain whether a dose response measured by salivary flow could be obtained for imipramine and dimethacrin, a developmental drug with fewer anticholinergic effects in animals. A further objective was to study the effects of both drugs on subjective feelings of mood, appetite, and dry mouth in order to make correlations between these effects and the anticholinergic activity. Results showed a linear log-dose response reduction in salivation for imipramine which differed significantly from placebo and dimethacrin. Significant changes on the Clyde Mood Scale in sleepiness and friendliness factors occurred only with imipramine, raising the question of whether there is a causal relationship between the central actions of imipramine and its anticholinergic activity. The significant decrease in friendliness with imipramine as compared to placebo suggests that anticholinergic activity is unlikely to be responsible for antidepressant effect, but may account for the drug's sedative action.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bassett, J. R., Carincross, K. D., Hacket, N. B., Storey, M.: Studies on the peripheral pharmacology of fenazoxine, a potential antidepressant drug. Brit. J. Pharmacol. 37, 69–78 (1969).
Bilikiewicz, T.: Les comas atropiniques et leur valeur therapeutique. Ann. med.- psychol. 127, 1–13 (1969).
Blackwell, B., Ayd, F.: The problems of evaluating a new antidepressant (dimethacrin) in prison volunteers. J. clin. Pharmacol. 11, 19–26 (1971).
Busfield, B. L., Wechsler, H.: Studies of salivation in depression. Arch. gen. Psychiat. 4, 10–15 (1961).
— —: Salivation rate: a physiologic correlate of improvement in hospitalized depressed patients treated with three antidepressant medications. Psychosom. Med. 24, 337–342 (1962).
Clyde, D. J.: Manual for the Clyde Mood Scale. Coral Gables, Florida, Biometric Laboratory, University of Miami (1963).
Cochran, W. G., Cox, G. M.: Experimental Design. 2nd ed. New York: John Wiley and Sons, Inc. 1957.
Cox, D. R.: Planning of Experiments. New York: John Wiley and Sons, Inc. 1958.
Data on file with Merrell-National Laboratories.
Davies, B. M., Gurland, J. B.: Salivary secretion in depressive illness. J. psychosom. Res. 5, 269–271 (1961).
DiMascio, A., Shader, R. I., Harmatz, J.: Psychotropic drugs and induced hostility. Psychosomatics 10, 47–50 (1969).
Fisher, Sir Ronald A., Yates, F.: Statistical Tables. 6th ed. New York: Hafner Publ. Comp., Inc. 1963.
Gluckman, M. I., Baum, T.: The pharmacology of iprindole, a new antidepressant. Psychopharmacologia (Berl.) 15, 169–185 (1969).
Gottlieb, G., Paulson, G.: Salivation in depressed patients. Arch. gen. Psychiat. 5, 468–471 (1961).
Gyermek, L.: The pharmacology of imipramine and related antidepressants. Int. Rev. Neurobiol. 9, 95–143 (1966).
Itil, T. M.: Anticholinergic drug-induced sleep-like EEG pattern in man. Psychopharmacologia (Berl.) 14, 383–393 (1969).
Jahn, U., Hausler, G.: Pharmacological effects of 9-9 dimethyl-10-dimethylamino-propylacridine bitartrate (SD 709). Wien. klin. Wschr. 78, 21–25 (1966).
Jones, R. J. M.: The effect of a large dose of atropine upon the performance of routine tasks. Brit. J. Pharmacol. 37, 301–305 (1969).
Klein, D. F., Davis, J. M.: Diagnosis and Drug Treatment of Psychiatric Disorders. Baltimore: Williams and Wilkins 1969.
Li, C. C.: Introduction to Experimental Statistics. New York: McGraw Hill Book Comp. 1964.
Palmai, G., Blackwell, B.: The diurnal pattern of salivary flow in normal and depressed patients. Brit. J. Psychiat. 111, 334–338 (1965).
— —, Maxwell, A. E., Morgenstern, F.: Patterns of salivary flow in depressive illness and during treatment. Brit. J. Psychiat. 113, 1297–1308 (1967).
Peck, R. E.: Salivary secretion in depressive illness. Arch. gen. Psychiat. 1, 35 (1959).
Peng, K. C.: The Design and Analysis of Scientific Experiments. London: Addison-Wesley Publ. Comp. 1967.
Silverstone, J. T., Stunkard, A. J.: The anorectic effect of dexamphetamine sulphate. Brit. J. Pharmacol. 33, 513–522 (1968).
Sokal, R. R., Rohlf, F. J.: Biometry, p. 237. San Francisco: Freeman and Comp. 1969.
Taber, R. I., Barnett, A., Roth, F. E.: The pharmacology of SCH 12650, a potential antidepressant. Pharmacologist 11, 247 (1969).
Vaillant, G. E.: Clinical significance of anticholinergic effects of imipramine-like drugs. Amer. J. Psychiat. 125, 1600–1602 (1969).
Vojtechovsky, M.: The action of central cholinolytics in a test on normal volunteers. Arzneimittel-Forsch. 19, 456–458 (1969).
White, R. P., Boyajy, L. D.: Neuropharmacological comparison of atropine, scopolamine, benactyzine, diphenhydramine, and hydroxyzine. Arch. int. Pharmacodyn. 127, 260–273 (1960).
Winer, B. J.: Statistical Principles in Experimental Design. New York: McGraw-Hill Book Comp. 1962.
Yates, F.: Incomplete Latin Squares. J. Agr. Sci. 26, 301–315 (1963).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blackwell, B., Lipkin, J.O., Meyer, J.H. et al. Dose responses and relationships between anticholinergic activity and mood with tricyclic antidepressants. Psychopharmacologia 25, 205–217 (1972). https://doi.org/10.1007/BF00422502
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00422502